.Novo Nordisk is proceeding its own push right into hereditary medicines, agreeing to pay NanoVation...
.Innovent Biologics has produced the case that its gate inhibitor-cytokine blend protein has a futur...
.A period 3 trial of Daiichi Sankyo as well as Merck & Co.'s HER3-directed antibody-drug conjugat...
.Five months after Rakovina Therapeutics turned toward artificial intelligence, the cancer-focused b...
.Ascendis Pharma has actually emerged as a potential risk to BioMarin's Voxzogo, stating period 3 gr...
.Though Alkeus Pharmaceuticals' oral eye condition asset stopped working to significantly lower geog...
.With a trio of biotechs striking the Nasdaq on Friday, it was quick and easy to overlook a smaller-...
.Invulnerable gate inhibitors are the superheroes of cancer treatment. Medications like Bristol Myer...
.Welcome to recently's Chutes & Ladders, our summary of considerable leadership hirings, shooting...
.Regeneron is back with long-lasting follow-up for its LAG-3 prevention as well as PD-1 inhibitor co...